A multi-centre, open-label study to assess the safety of Stimuvax (BLP25 liposome vaccine or L-BLP25) in non-small cell lung cancer (NSCLC) patients (pts) with unresectable stage III disease Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Soulieres, D
  • Smith, C
  • Ellis, Peter
  • Murray, N
  • Jasas, K
  • Maksymiuk, A
  • Goss, G
  • Falk, MH
  • Butts, C

publication date

  • June 20, 2007